Characterizing Osteologic Effects of Cholesteatoma and Oncolytic Virotherapy

Characterizing Osteologic Effects of Cholesteatoma and Oncolytic Virotherapy

Bibliographic Details
Main Author:	Pinkl, Joseph T.
Language:	English
Published:	University of Cincinnati / OhioLINK 2021
Subjects:	Audiology cholesteatoma oncolytic herpes simplex virus virotherapy bone mineral density bone resorption micro computed tomography
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=ucin1627663262820533

Similar Items

Presage of oncolytic virotherapy for oral cancer with herpes simplex virus
by: Yoshiaki Yura
Published: (2017-05-01)

Engineered oncolytic virus for the treatment of cholesteatoma: A pilot in vivo study
by: Ravi N. Samy, et al.
Published: (2019-10-01)

Oncolytic herpes viruses, chemotherapeutics, and other cancer drugs
by: Braidwood L, et al.
Published: (2013-12-01)

Proteomic Analysis of Secretomes of Oncolytic Herpes Simplex Virus-Infected Squamous Cell Carcinoma Cells
by: Shinya Tada, et al.
Published: (2018-01-01)

A novel fusogenic herpes simplex virus for oncolytic virotherapy of squamous cell carcinoma
by: Iwai Soichi, et al.
Published: (2011-06-01)

Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy
by: Jie Yin, et al.
Published: (2017-06-01)

Oncolytic HSV: Underpinnings of Tumor Susceptibility
by: Chase Kangas, et al.
Published: (2021-07-01)

Oncolytic Virotherapy with Myxoma Virus
by: Masmudur M. Rahman, et al.
Published: (2020-01-01)

Oncolytic Herpes Simplex Virus-Based Therapies for Cancer
by: Norah Aldrak, et al.
Published: (2021-06-01)

Oncolytic Virotherapy in Glioma Tumors
by: Sergio Rius-Rocabert, et al.
Published: (2020-10-01)

From Benchtop to Bedside: A Review of Oncolytic Virotherapy
by: Audrey H. Choi, et al.
Published: (2016-08-01)

Oncolytic virotherapy for pediatric malignancies: future prospects
by: Waters AM, et al.
Published: (2016-08-01)

Editorial announcing PubMed indexing of Oncolytic Virotherapy
by: Farassati F
Published: (2017-02-01)

Development of a Novel Model for Exploring the Role of Regulatory T-cells in Oncolytic HSV Cancer Therapy
by: Baird, William H.
Published: (2011)

Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus
by: Takuma Suzuki, et al.
Published: (2021-09-01)

Herpes Simplex Virus Oncolytic Immunovirotherapy: The Blossoming Branch of Multimodal Therapy
by: Laura Menotti, et al.
Published: (2020-11-01)

Oncolytic virotherapy for head and neck cancer: current research and future developments
by: Malhotra A, et al.
Published: (2015-07-01)

Oncolytic virotherapy for ovarian cancer
by: Li SD, et al.
Published: (2012-08-01)

Oncolytic Virotherapy and Microenvironment in Multiple Myeloma
by: Valentina Marchica, et al.
Published: (2021-02-01)

Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy
by: Olga V. Matveeva, et al.
Published: (2020-12-01)

Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy
by: Valentina Marchica, et al.
Published: (2020-07-01)

Delivery and Biosafety of Oncolytic Virotherapy
by: Lizhi Li, et al.
Published: (2020-04-01)

Chemovirotherapy: combining chemotherapeutic treatment with oncolytic virotherapy
by: Binz E, et al.
Published: (2015-02-01)

Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives
by: Mahmood A. Hamed, et al.
Published: (2016-12-01)

Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins
by: Xiao-Qin Liu, et al.
Published: (2018-01-01)

The Continued Promise and Many Disappointments of Oncolytic Virotherapy in Gastrointestinal Malignancies
by: Daniel H. Ahn, et al.
Published: (2017-03-01)

Oncolytic virotherapy for human malignant mesothelioma: recent advances
by: Boisgerault N, et al.
Published: (2015-09-01)

Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer
by: Andrew eNguyen, et al.
Published: (2014-06-01)

Treating cancerous cells with viruses: insights from a minimal model for oncolytic virotherapy
by: Adrianne L. Jenner, et al.
Published: (2018-06-01)

Combining HDAC inhibitors with oncolytic virotherapy for cancer therapy
by: Nakashima H, et al.
Published: (2015-11-01)

Targeting tumor vasculature through oncolytic virotherapy: recent advances
by: Toro Bejarano M, et al.
Published: (2015-11-01)

Oncolytic Herpes Simplex Viral Therapy: A Stride toward Selective Targeting of Cancer Cells
by: Dhaval S. Sanchala, et al.
Published: (2017-05-01)

Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances
by: Simpson GR, et al.
Published: (2016-01-01)

Application of control theory in a delayed-infection and immune-evading oncolytic virotherapy
by: Taeyong Lee, et al.
Published: (2020-01-01)

Oncolytic Virotherapy for Cancer: Clinical Experience
by: Shyambabu Chaurasiya, et al.
Published: (2021-04-01)

Effective Treatment of Glioblastoma Multiforme With Oncolytic Virotherapy: A Case-Series
by: Benjamin Gesundheit, et al.
Published: (2020-05-01)

ONCOLYTIC VIROTHERAPY IN GLIOBLASTOMA TREATMENT: PROGRESS AND CHALLENGES IN CLINICAL RESEARCH (LITERATURE REVIEW)
by: O. I. Kit, et al.
Published: (2020-12-01)

Generation of an Oncolytic Herpes Simplex Viral Vector Completely Retargeted to the GDNF Receptor GFRα1 for Specific Infection of Breast Cancer Cells
by: Bonnie L. Hall, et al.
Published: (2020-11-01)

Measles to the Rescue: A Review of Oncolytic Measles Virus
by: Sarah Aref, et al.
Published: (2016-10-01)

Oncolytic virotherapy
by: Daniel Cervantes-García;, et al.
Published: (2008-01-01)